Status: Recruiting
Restoration of Hypoglycemia Awareness With Metoclopramide
Metoclopramide is a drug approved by the FDA for gastroesophageal reflux and to relieve symptoms in adults with acute and recurrent diabetic gastroparesis. The objective of this study is to determine whether metoclopramide can improve hypoglycemia awareness and decrease the incidence of hypoglycemia in type 1 diabetes patients with hypoglycemia unawareness.
Participants needed: 36
Trial details
Phase: Phase 2Age: 20-60Biological sex: AllType: InterventionalSponsor: Simon FisherUpdated: Mar 20, 2026Locations: 2
Eligibility criteria
Subjects with Type 1 Diabetes Mellitus [+3]
History of myocardial infarction, cardiac arrhythmia, congestive heart failure a... [+11]